L+G-L+G PHARMA BREAKTHR.
L+G-L+G PHARMA BREAKTHR.
ETF · IE00BF0H7608 · A2H9XR (XLON)
Overview
9,61 EUR
0,70 % 0,07 EUR
Closing Price XLON 09.06.2025: 809,80 GBX
London (XETR) · Current prices and charts at MoneyPeak
09.06.2025 15:36

Current Prices from L+G-L+G PHARMA BREAKTHR.

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
ETLI.DE
EUR
09.06.2025 15:36
9,61 EUR
9,55 EUR
+0,70 %
XLON: London
London
BIGT.L
GBX
09.06.2025 14:13
809,80 GBX
804,20 GBX
+0,70 %
XLON: London
London
BIOT.L
USD
09.06.2025 14:03
10,97 USD
10,86 USD
+1,01 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 1,36 % 4,54 % -4,70 % -4,96 % 6,81 % -8,13 %

Company Profile for L+G-L+G PHARMA BREAKTHR. ETF

The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.

Company Data

Name L+G-L+G PHARMA BREAKTHR.
Company L&G Pharma Breakthrough UCITS ETF
Primary Exchange XLON London
WKN A2H9XR
ISIN IE00BF0H7608
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 20 Mio
Country Ireland
Currency EUR
Employees -
IPO Date 2018-01-18

Ticker Symbols

Name Symbol
Frankfurt ETLI.F
London BIGT.L
London BIOT.L
XETRA ETLI.DE

More Shares

Investors who L+G-L+G PHARMA BREAKTHR. hold also have the following shares in their portfolio:
BMW FIN. 23/35 MTN
BMW FIN. 23/35 MTN Bond
Value Line Asset Allocation Fund Institutional Class
Value Line Asset Allocation Fund Institutional Class Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025